MARLBOROUGH, Mass. / Apr 02, 2024 / Business Wire / Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the second quarter of fiscal 2024 on Thursday, May 2, after the market closes. In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time.
Interested participants may listen to the call by dialing (888) 256-1007 (in the United States and Canada) or +1 (773) 305-6853 (for international callers) and referencing access code 7680382. Participants may also click here to join. Participants should dial in 5-10 minutes before the call begins.
Hologic will provide a live and webcast replay of the call on the Company’s website at www.investors.hologic.com. The call will be available there for 30 days. The webcast replay will be available approximately two hours after the call ends.
About Hologic
Hologic, Inc. is an innovative medical technology company primarily focused on improving women's health and well-being through early detection and treatment. For more information on Hologic, visit www.hologic.com.
| Last Trade: | US$66.73 |
| Daily Change: | 0.10 0.15 |
| Daily Volume: | 982,598 |
| Market Cap: | US$14.840B |
April 24, 2025 | |
Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MORE
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MORE
